Lataa...
Cellular and Molecular Chaperone Fusion Vaccines: Targeting Resistant Cancer Cell Populations
Molecular chaperone-based vaccines offer a number of advantages for cancer treatment. We have discussed the deployment of a vaccine prepared by gentle isolation of Hsp70 from tumor dendritic cell fusions (Hsp70 fusion vaccine). The vaccine was highly effective in triggering specific T cell immunity...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4100618/ https://ncbi.nlm.nih.gov/pubmed/23682824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/02656736.2013.792126 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|